RecruitingNot ApplicableNCT06892847

Brain STimulation for ANxiety and Depression in Youth

Brain STimulation for ANxiety and Depression in Youth: Brain STAND


Sponsor

University of Calgary

Enrollment

120 participants

Start Date

Jul 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

In this open-label trial, the overall aim is to determine if TMS treatment can improve anxiety and depression in a broad group of children and youth referred by physicians.


Eligibility

Min Age: 6 YearsMax Age: 18 Years

Inclusion Criteria3

  • aged between 6 and 18 years old
  • diagnosis of anxiety or depression made by a qualified medical professional
  • active anxiety and/or depression symptoms

Exclusion Criteria6

  • status epilepticus in past 12-months
  • presence of any disease, medical condition, or physical condition that, in the opinion of the study investigator may compromise, interfere, limit, affect, or reduce the participant's ability to complete the study
  • hospitalization for suicide attempt within the past 3 months (unless participant is under the daily supervision of a physician, such as in a mental health day treatment program)
  • TMS-related contraindications, including implanted medical devices (e.g., pacemaker)
  • if actively taking prescription medication, no changes in medication for at least 3 months prior to entry into the study, with no anticipation of change in the frequency or dose over the duration of the study, unless changes to medication are required for participant safety
  • unable to understand instructions in English

Interventions

PROCEDURETranscranial Magnetic Stimulation

Participants will receive TMS for treatment measures as determined by referral and presentation.


Locations(1)

Alberta Children's Hospital

Calgary, Alberta, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06892847


Related Trials